Astellas Pharma · 5 hours ago
Clinical Modeling & Analytics Innovation Scientist
Northbrook, IL
Full-time
Hybrid
Mid, Senior Level
$122K/yr - $192K/yr
3+ years expAstellas Pharma is a global pharmaceutical company dedicated to developing innovative therapies for patients. The Clinical Modeling & Analytics Innovation Scientist will leverage advanced analytics, AI/ML, and modeling to enhance clinical trial strategies and execution, collaborating with various teams to optimize trial planning and patient recruitment.
BiotechnologyHealth CareMedical
Responsibilities
Contributes to cross-functional initiatives by collaborating with cross-functional teams and applying clinical modeling & simulation, advanced analytics, and AI/ML to trial design, feasibility, and execution optimization
Implements and delivers simulation and predictive models to inform and optimize clinical trial planning, protocol development, patient recruitment and retention across therapeutic areas
Contributes to the development and maintenance of clinical modeling & data strategy and roadmap dedicated to specific business areas
Collaborates with medical, biostatistics, real-world data, and operational teams to embed clinical modeling & analytics insights into protocol development, portfolio planning and decision-making
Stays current with emerging technologies, proposes and develops innovative modeling and analytics methodologies, and leads or contributes to internal training and external publications and presentations
Qualification
Required
Advanced degrees in Statistics/Biostatistics, Data Science, Artificial Intelligence, Machine Learning, Epidemiology, Computational Biology, Informatics, or related quantitative disciplines
PhD with minimum 3+ years of experience or MS with minimum 6+ years of experience in pharma/biotech, CROs or healthcare settings
Deep understanding of quantitative theories in statistical modeling, AI/ML and independent project experience from planning to delivery
Strong hand-on skills with one or more programing languages (i.e., R, Python, Julia, SAS, SQL etc.) for data manipulation, analysis and visualization
Familiar with various data sources (i.e., clinical trials, RWD), and relevant standards (CDISC, OMOP, CTMS etc.) in clinical development and operations
Preferred
Experience with development and deployment of generative AI solutions (i.e., LLMs or foundational models), digital twins or medical imaging analytics etc
Track record of quantitative expertise in advanced analytics, modeling & simulation and AI/ML, i.e., with publications and presentations
Experience with MLOps and workflow development within cloud platforms (Azure, AWS, GCP etc.)
Exposure to multiple therapeutic areas (i.e., oncology, ophthalmology, rare disease etc) and therapeutic modalities (i.e., small molecules, antibodies, bispecific, ADCs or targeted protein degradation, cell & gene therapy, etc.)
Benefits
Medical, Dental and Vision Insurance
Generous Paid Time Off options, including Vacation and Sick time, plus national holidays including year-end shut down
401(k) match and annual company contribution
Company paid life insurance
Annual Corporate Bonus and Quarterly Sales Incentive for eligible positions
Long Term Incentive Plan for eligible positions
Company fleet vehicle for eligible positions
Referral bonus program
Company
Astellas Pharma
Astellas Pharma is a global pharmaceutical research & development company.
10001+ employees
H1B Sponsorship
Astellas Pharma has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2023 (4)
2022 (2)
2021 (3)
2020 (5)
Funding
Current Stage
Public CompanyTotal Funding
unknownKey Investors
National Institute on Drug Abuse (NIDA)
2020-07-22Grant
2008-10-13IPO
Leadership Team
Amanda Hart
Head, Global Commercial Analytics and Reporting
Recent News
2026-01-07
Company data provided by crunchbase